Nov. 14 at 7:45 PM
$AIFF
The Firefly–Cognito collaboration is likely game-changing because it combines a neuromodulation therapy (Cognito) with the world’s largest standardized EEG/ERP database and AI-driven biomarkers (Firefly). Cognito needs objective, brain-based markers to identify responders, track treatment effects, and support future regulatory filings. Firefly’s new CLEAR hardware delivers cleaner, higher-fidelity EEG data ideal for detecting these subtle neural changes. If the partnership validates reliable treatment-response biomarkers, it could create the first scalable